ReviewJournal for immunotherapy of cancer2022

OxMIF: a druggable isoform of macrophage migration inhibitory factor in cancer and inflammatory diseases.

Michael Thiele et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.